Key result
CMR remains the non-invasive gold standard for myocarditis, reserving EMB for life-threatening fulminant cases.
Why the study?
The rising incidence, diverse etiologies, variable clinical presentations, and high mortality of myocarditis create challenges for diagnostic modality selection and appropriate therapeutic approaches.
Design
Review
Authors
Loading...
Supports selective biopsy use in fulminant myocarditis; extends reviews but leaves optimal thresholds open for prospective study.
This review provides an update on the etiology, diagnosis, and management of myocarditis, highlighting the role of cardiac MRI and endomyocardial biopsy.
Lasica et al. (2023) conducted a review in Myocarditis. Cardiac magnetic resonance imaging is the non-invasive diagnostic gold standard for myocarditis, while endomyocardial biopsy is reserved for life-threatening cases with suspected fulminant myocarditis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: